News roundup Monday, March 31

In addition to this, you need to know more about it.

Do you follow our Newsletter? Sign up here!

The latest news

Infant Bacterial Therapeutics is granted “Breakthrough Therapy Designation” for its drug candidate. Read more.

Novo Nordisk announces that Ozempic showed improved walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease. Read moreThe company also announces that Rybelsus shows superior reduction in cardiovascular events. Read more.

informs about positive results from the company's preclinical validation study with biobank plasma samples. Read more.

Vivesto signs an agreement with Kazia Therapeutics to acquire full rights to Cantrixi. Read more.

Prostatype Genomics announces positive preliminary results for the primary endpoint in the US study with Prostatype. Read more.

AstraZeneca announces that Imfinzi has been approved in the US as the first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer. Read moreThe company also announces that Calquence plus chemoimmunotherapy is recommended for approval in the EU by the CHMP as first-line treatment of mantle cell lymphoma. Read more.

Carbiotix receives signed LOI regarding the first NutraCycle license agreement. Read more.

Diagonal Cinema announces further pilot tests of LAMPlify. Read more.

STENOCARE Sales of the new CBD100 oil product begin in Denmark. Read more.

PolarCool signs an agreement with the Czech Republic's top ice hockey league. Read more.

Navamedic has received a letter from the Norwegian Financial Supervisory Authority regarding the accounting of Navamedic's loan to Observe Medical in relation to the company's annual report for 2023. Read more.

Regulatory condition met for the license agreement between AbbVie and Gubra. Read more.

Iconovo obtains new patent for ICOres in Europe. Read more.

Integral implements new compensation package for CEO. Read more.

NextCell Pharma announces that the company's Chief Scientific Officer (CSO), Dr. Lindsay Davies, has been elected to the board of directors of ATMP Sweden. Read more.

Gentian Diagnostics has recruited Markus Jaquemar to the role of Chief Growth Officer and Hanne Kjellevold Kristiansen to the role of Vice President, Commercial. Read more.

Gradientech appoints new sales manager for Central Europe. Read more.